Sepsis Institutional Registry in Hospital Italiano de Buenos Aires

The purpose of this study is to create an institutional registry of sepsis through a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Death Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Sepsis Severe Sepsis Systemic Inflammatory Response Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Italiano de Buenos Aires, Gascon 450

Buenos Aires, Argentina

About this study

The main goal is to describe the occurrence of sepsis and the characteristics of clinical presentation, evolution and predisposing factors within the population of the Hospital Italiano de Buenos Aires.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Over 17 years
Two or more sirs criteria
Active infection

Exclusion criteria

Refusal to register or to the informed consent process
Ambulatory patients

Treatment and study plan

Primary outcomes

clinical features, mortality

Time frame: Clinical characteristics are evaluated during the acute event and in-hospital mortality and annual monitoring

Sponsors and collaborators

Lead sponsor

Hospital Italiano de Buenos Aires

Other

Registry information

Acronym: SIR

Important dates

Study start: 2007
Primary completion: 2014
Study completion: 2014
First posted: Jul 27, 2011
Registry last updated: Aug 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed